Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06062342 · ClinicalTrials.gov registry record · NA
Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities
A NA study of HIV, sponsored by University of Miami.
- Recruiting
- Registry status
- NA
- Development phase
- 20,400
- Enrollment target
- 1
- Study location
NCT06062342: Recruiting NA study of HIV, sponsored by University of Miami.
NCT06062342 is a NA study of HIV that is actively recruiting participants, run by University of Miami. The registered enrollment target is 20,400 participants, above the 373-participant average among 303 other HIV trials with a reported enrollment target (5369% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06062342, a NA study of HIV, is actively recruiting participants, sponsored by University of Miami.
- RECRUITING
- Registry status
- NA
- Development phase
- 20,400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.
Primary Outcome
Will be reported as proportion of residents with recent (within 12 months) HIV testing as measured by Five Point Initiative - Community Survey
Conditions Studied
Interventions
- BEHAVIORAL FPI
Study Locations (1)
Florida
- University of Miami - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,400 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2029-06-30 |
| Phase | NA |
What NCT06062342 shows while recruiting
NCT06062342 is an interventional study that assigns participants to a tested intervention. Its 20,400 participants enrollment target places it among the larger protocols in the corpus, above the 373-participant average among 303 other HIV trials with a reported enrollment target (5369% higher).
The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which FPI is the first listed.
NCT06062342 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT06062342 about?
NCT06062342 is a clinical study titled "Five Point Initiative: A Bundled Implementation Strategy to Address the HIV Epidemic in Black Communities". The purpose of this study is to assess the effectiveness of the FPI bundled implementation strategy in increasing HIV testing, Pre-exposure prophylaxis (PrEP) linkage (e.g., prescription) and knowledge, and condom use/access.
What is the current status of trial NCT06062342?
This trial is currently recruiting. It is a NA study. The enrollment target is 20,400 participants. The study started on 2024-02-02. Estimated completion is 2029-06-30.
What conditions does trial NCT06062342 study?
This clinical trial studies the following conditions: HIV.
What interventions are being tested in trial NCT06062342?
The interventions under investigation include: FPI (BEHAVIORAL).
Who is sponsoring clinical trial NCT06062342?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06062342 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06062342's enrollment target sits among peer trials
20,400 1st of 303 higher than 303 of 303 other HIV trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
RECRUITING · NA
-
1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV
RECRUITING · NA
-
Implementation Trial to Evaluate a Population Health Combination Intervention to Meet HIV Testing, Linkage, and Viral Suppression Goals in Alabama
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Assessing Peer Support for Physical Activity in Women With HIV and Hypertension
RECRUITING · NA
-
Open Trial of Trauma-focused Psychodynamic Psychotherapy for People Living With HIV and PTSD
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI